Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(8 sites)
United States
University of California, San Francisco, San Francisco, California University of Maryland, College Park, Maryland University of Michigan, Ann Arbor, Michigan Henry Ford Health, Detroit, Michigan Duke University Medical Center, Durham, North Carolina Wake Forest University School of Medicine, Winston-Salem, North Carolina UT Southwestern Medical Center, Dallas, Texas University of Virginia, Charlottesville, Virginia